Enforced polarization of melanoma cells towards a JARID1B-high phenotype exhausts tumour fitness
Heike Chauvistré(Vrije Universiteit Brussel), Nikolas K. Haass(The University of Queensland), Felix C. E. Vogel(German Cancer Research Center), Batool Shannan(Vrije Universiteit Brussel), Alexander Roesch(University of Regensburg), Meenhard Herlyn(The Wistar Institute), Q. Liu, Dirk Schadendorf(University of Mannheim), Clemens Krepler(Merck & Co., Inc., Rahway, NJ, USA (United States)), Oliver Keminer(Fraunhofer Institute for Translational Medicine and Pharmacology), Marc Remke(Düsseldorf University Hospital), Claudia Becher, A. Hoewner(University of Duisburg-Essen), Şule Karabulut Gül, Daniel Picard(Heidelberg University), Andrea Sechi, N. Lorberg, Sheena M. Daignault(The University of Queensland), D. Zarschler
RWTH Publications (RWTH Aachen)
January 1, 2017
Cited by 1
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
|Journal of Clinical Oncology|2015|2.1k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.4k
Colorectal carcinoma antigens detected by hybridoma antibodies
|Somatic Cell and Molecular Genetics|1979|1.4k
A Tumorigenic Subpopulation with Stem Cell Properties in Melanomas
|Cancer Research|2005|1.3k